Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis.

Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol. 2021; 12(3):1001-1019.

View in: PubMed

subject areas

Animals
Bile Acids and Salts
Cholesterol
Combined Modality Therapy
Dependovirus
Disease Models, Animal
Fibroblast Growth Factors
Fructose
Gene Expression Profiling
Gene Expression Regulation
Genetic Therapy
Genetic Vectors
Male
Methylamines
Mice
Non-alcoholic Fatty Liver Disease
Thiazepines
Treatment Outcome

authors with profiles

Jacob Friedman
Tiangang Li